Structure Therapeutics Inc.

Structure Therapeutics Inc. (GPCR) priced its initial public offering on Feb 6, 2023 at $15.00 per ADS, within its $13.00–$15.00 range, raising $161.1M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $548.8M. Jefferies was lead-left underwriter, joined by SVB, Guggenheim and BMO Capital Markets. Cooley, Travers Thorp Alberga and Zhong Lun advised the company and Latham & Watkins advised the underwriters.

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing oral small molecule therapeutics for chronic diseases, including metabolic, cardiovascular and pulmonary conditions. It uses structure-based drug discovery and computational chemistry, initially targeting G-protein-coupled receptors.

Status

IPO

Ticker

GPCR

Exchange

Nasdaq Global Market

Priced

Feb 6, 2023

IPO price

$15.00 per ADS

Price range

$13.00–$15.00

Raised

$161.1M

Market cap at IPO price

$548.8M

First filed

Jan 12, 2023

Underwriters

Jefferies, SVB, Guggenheim and BMO Capital Markets

Company counsel

Cooley, Travers Thorp Alberga and Zhong Lun

Underwriters' counsel

Latham & Watkins

Sector

Biotech & pharma

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.